The Use of Fiducial Markers for IGRT in Prostate Cancer
Brian J. Davis(Southwest Research Institute), Michael Herman(Borland Groover Clinic), Jon J. Kruse(Mayo Clinic), Christopher C. Goulet
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
|Journal of the National Comprehensive Cancer Network|2021|532
Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma
|Circulation|2001|347